Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid injection for melasma (split-face randomized double-blind study)
TCTR20240731005Phase 3Completed
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in melasma, sponsored by none. Started Jul 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20240731005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240731005.